Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer
NCT05076851
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Neoadjuvant Therapy \High Risk Prostate Cancer
Interventions
OTHER:
placebo
DRUG:
Proxalutamide
Sponsor
Hongqian Guo